Dataintelo forecasts that the global Docetaxel Trihydrate API Market is expected to reach USD 1.47 billion by 2032, growing at a CAGR of 5.9% from USD 875 million in 2023. The market's expansion is attributed to the rising global cancer burden, increasing demand for chemotherapy drugs, and growing investment in oncology R&D.
Docetaxel Trihydrate, a prominent anti-mitotic chemotherapy...